Ubiquitous clot contraction blockers hit ubiquitin and more.

John W Weisel, Rustem I Litvinov
Author Information
  1. John W Weisel: Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. ORCID
  2. Rustem I Litvinov: Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

Abstract

No abstract text available.

References

  1. Res Pract Thromb Haemost. 2022 Dec 23;7(1):100023 [PMID: 36760777]
  2. Sci Rep. 2020 Mar 20;10(1):5112 [PMID: 32198356]
  3. Int J Mol Sci. 2023 Jun 25;24(13): [PMID: 37445780]
  4. Blood Adv. 2025 Mar 11;9(5):1049-1068 [PMID: 39374578]
  5. Cell Oncol (Dordr). 2024 Aug;47(4):1071-1089 [PMID: 38324230]
  6. Blood Adv. 2021 Oct 26;5(20):3986-4002 [PMID: 34647980]
  7. Blood. 2014 Mar 6;123(10):1596-603 [PMID: 24335500]
  8. Blood Adv. 2021 Dec 14;5(23):4901-4909 [PMID: 34570183]

Word Cloud

Created with Highcharts 10.0.0Ubiquitousclotcontractionblockershitubiquitinmore

Similar Articles

Cited By

No available data.